Tag Archive: Neuroblastoma

Sep 15 2014

Scholar Hope Grant Supports Neuroblastoma Research

Pediatric oncology researchers at The Children’s Hospital of Philadelphia are driven to find new treatments for childhood cancer, and the Hyundai Hope On Wheels program is supporting their hard work by awarding a 2014 Scholar Hope grant to help fund investigations that focus on the aggressive form of neuroblastoma.

Permanent link to this article: http://www.research.chop.edu/blog/scholar-hope-grant-supports-neuroblastoma-research/

May 20 2014

Oncologist Honored for Neuroblastoma Research

The Advances in Neuroblastoma Research Association (ANRA) recently presented its highest honor to pediatric oncologist Garrett M. Brodeur, MD, of the Cancer Center at The Children’s Hospital of Philadelphia (CHOP).

Permanent link to this article: http://www.research.chop.edu/blog/lifetime-achievement-award-honors-chop-expert-garrett-brodeur-career-work-neuroblastoma/

Aug 29 2013

Proton Therapy Offers New, Precise Cancer Treatment for Children with High-Risk Neuroblastoma

Proton therapy, which uses high-energy subatomic particles, may offer a precise, organ-sparing treatment option for children with high-risk forms of neuroblastoma, the most common solid tumor of early childhood.

Permanent link to this article: http://www.research.chop.edu/blog/proton-therapy-offers-new-precise-cancer-treatment-children-high-risk-neuroblastoma/

Aug 13 2013

St. Baldrick’s Foundation Awards Children’s Hospital More than $650,000

Monrovia, Calif.-based St. Baldrick’s Foundation recently announced $699,186 in grants to one consortium and three cancer researchers at CHOP.

Permanent link to this article: http://www.research.chop.edu/blog/st-baldricks-foundation-awards-childrens-hospital-more-than-650000/

Jul 19 2013

CHOP Cancer Experts Awarded Alex’s Lemonade Stand Grants

As part of its mission to find “a cure for all children with cancer,” Alex’s Lemonade Stand Foundation recently announced more than $7 million in new grants to researchers around the country, including four at The Children’s Hospital of Philadelphia. Children’s Hospital investigators Garrett Brodeur, MD, Michael Hogarty, MD, Richard Aplenc, MD, and Robert Schnepp, …

Continue reading »

Permanent link to this article: http://www.research.chop.edu/blog/chop-cancer-experts-awarded-alexs-lemonade-stand-grants/

Jul 03 2013

CHOP Cancer Expert Garrett Brodeur Honored with Pediatric Oncology Award and Lecture

The American Society of Clinical Oncology will confer one of its highest awards on Garrett M. Brodeur, MD, who will receive the Pediatric Oncology Award and deliver the Pediatric Oncology Lecture.

Permanent link to this article: http://www.research.chop.edu/blog/chop-cancer-expert-garrett-brodeur-honored-with-pediatric-oncology-award-and-lecture/

Jun 03 2013

CBS Sunday Morning Features ALK Cancer Trial at Children’s Hospital

Yesterday, CBS Sunday Morning featured a story on the anaplastic lymphoma kinase, or ALK, clinical trial for lymphoma and neuroblastoma and CHOP’s partnership with the Alex’s Lemonade Stand Foundation, which supported the basic research.

Permanent link to this article: http://www.research.chop.edu/blog/cbs-sunday-morning-features-alk-cancer-trial-at-childrens-hospital/

Jan 24 2013

Study Shows Neuroblastoma Evolves Rapidly, Limiting Treatment Targets

A recent genomic study of neuroblastoma reinforces the challenges of treating the most aggressive forms of this disease. Contrary to expectations, the researchers found relatively few recurrent gene mutations — mutations that would suggest new targets for neuroblastoma treatment. Instead, the investigators have refocused on how neuroblastoma tumors evolve in response to medicine and other factors.

Permanent link to this article: http://www.research.chop.edu/blog/study-shows-neuroblastoma-evolves-rapidly-limiting-treatment-targets/

Dec 06 2012

CHOP Researchers Identify Two Gene Mutations Linked to Neuroblastoma

For decades, researchers at The Children’s Hospital of Philadelphia have worked to better understand and treat neuroblastoma, a cancer of nerve tissue.Neuroblastoma is frequently aggressive, causing approximately 12 percent of all childhood cancer deaths. In high-risk forms of the disease, the cancer tends to return after initial treatment, often with deadly results. Using powerful gene-analysis …

Continue reading »

Permanent link to this article: http://www.research.chop.edu/blog/chop-researchers-identify-two-gene-mutations-linked-to-neuroblastoma/